Since the first report of G-CSF-producing malignant lung cancer in 1977, studies in cervical, head and neck, lung, gastric, bladder..., among others, described this particular biological characteristic, related with patient outcome [10–12]. The gene discussed is CSF3; the disease is lung carcinoma.